Literature DB >> 1361927

[Intralesional treatment of classical Kaposi sarcoma with interferon-alpha].

A Hauschild1, C Petres-Dunsche.   

Abstract

A 71-year-old female patient with classic Kaposi sarcoma (sarcoma idiopathicum haemorrhagicum multiplex) of the lower legs and one hand was treated with intralesional recombinant interferon alpha 2b. After 6 consecutive weeks of intratumoral injection of 1-3 million IU interferon-alpha 2b (Intron A) in three marked lesions, complete remission of intralesionally treated and of untreated tumours was observed. Even 9 months after treatment, the patient is still in complete remission. We conclude that this low dose and well-tolerated treatment schedule with interferon-alpha 2b is effective and a good alternative to radiation or chemotherapy in Kaposi sarcoma.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1361927

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  4 in total

Review 1.  Clinical uses of interferons.

Authors:  Robert M Friedman
Journal:  Br J Clin Pharmacol       Date:  2007-12-07       Impact factor: 4.335

Review 2.  Backs against the wall: novel and existing strategies used during the 2014-2015 Ebola virus outbreak.

Authors:  Gary Wong; Gary P Kobinger
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

3.  Kaposi Sarcoma in a Non HIV Patient.

Authors:  Rafi A Jan; Parvaiz A Koul; Manzoor Ahmed; Sonaullah Shah; Showkat A Mufti; Fayaz A War
Journal:  Int J Health Sci (Qassim)       Date:  2008-07

Review 4.  Interferons as Therapy for Viral and Neoplastic Diseases: From Panacea to Pariah to Paragon.

Authors:  Robert M Friedman; Sara Contente
Journal:  Pharmaceuticals (Basel)       Date:  2009-12-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.